Calm Logic
Explorer
As you've already suggested, plain KPV is likely one of the least stable grey peptides when it comes to lasting long enough to have any effect.lessthanhalf said:
From what I read in the research, the dose was 4mg daily, taken for 1 month. As far as I recall, its half-life is quite short — though that is true of most peptides, apart from the GLPs that were engineered to resist rapid breakdown. My guess is it behaves somewhat like mots-c, where the amounts given are hundreds of times above what the body naturally has, so being cleared very quickly does not really become a problem. A brief, intense spike of it changes how genes are expressed or does whatever else it does (I do not recall ARA-290's precise mechanism), and those downstream effects stick around for a good while even though the compound itself is gone fast. Even if it breaks down within minutes after reaching the blood, as happens with many short peptides, a subcutaneous injection still needs an hour or 2 to be absorbed, so measurable levels will be present for at least that long.
So, to answer: pinning more frequently could possibly be better, but when proper human trials exist instead of mere speculation, following the trial method makes the most sense, since those are the doses and schedules that were actually demonstrated to work.
Gemini: "ARA-290 is designed with a chemical cap and enough length that it can make it through its short trip in the bloodstream and still activate significant receptor-mediated anti-inflammatory signaling."